Brave Asset Management’s Idexx Laboratories IDXX Stock Holding History

Brave Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-310	Closed	-$24K	–	440
2015 Q1	$24K	Hold	310	–	–	0.02%	296
2014 Q4	$23K	Hold	310	–	–	0.02%	299
2014 Q3	$18K	Buy	+310	New	+$19.6K	0.01%	308

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brave Asset Management's IDXX Position: Q2 2015 in Review

Brave Asset Management sold out of Idexx Laboratories (IDXX) in Q2 2015, closing a stake of 310 shares — an estimated $24K sold.

Brave Asset Management first reported a position in IDXX in Q3 2014 and held it in 3 quarters. The position peaked at $24K in Q1 2015. 348 funds tracked by Wall St. Rank hold IDXX as of Q2 2015.

Brave Asset Management reported no remaining Idexx Laboratories position as of Q2 2015 after selling out during the quarter.
Brave Asset Management sold 310 Idexx Laboratories shares in Q2 2015, an estimated $24K.
Brave Asset Management first reported a position in Idexx Laboratories in Q3 2014 and held it in 3 quarters.
Brave Asset Management's Idexx Laboratories position peaked at $24K in Q1 2015.
348 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2015.

Based on Brave Asset Management's 13F filing for Q2 2015, filed 11 Aug 2015.